Table 4.
Follow-up of asymptomatic SDHx mutation carriers | Adults | Children |
---|---|---|
Initial screening | Clinical examination (including bp), biochemical testing, MRI (base of the skull to pelvis), [68Ga]-DOTA-SSA PET/CT | Clinical examination (including bp), biochemical testing, MRI (base of the skull to pelvis) (initiation: at the age of 6-10 and 10-15 years for SDHB and SDHA/C/D mutation carriers, respectively) |
Follow-up | Every 12 months clinical examination (including bp) & biochemical testing (plasma > urine), every 24-36 months MRI (base of the skull to pelvis) (no consensus on alternating MRI and PET/CT) | Every 12 months clinical examination (including bp), every 24 months biochemical testing, every 24-36 months MRI (base of the skull to pelvis) |
Abbreviations: bp, blood pressure; MRI, magnetic resonance imaging; PET/CT, positron emission tomography/computed tomography.